Skip to main content
Top
Published in: Journal of Gastrointestinal Cancer 1/2016

01-03-2016 | Case Report

Neuroendocrine Carcinoma of the Gallbladder Masquerading as a Klatskin Tumor in a 74-Year-Old Male

Authors: Fabian Kütting, Matthias Schmidt, Dirk Waldschmidt, Harald Curth, Christoph Schramm, Hans-Michael Steffen

Published in: Journal of Gastrointestinal Cancer | Issue 1/2016

Login to get access

Excerpt

Neuroendocrine carcinomas represent a heterogeneous tumor entity, which can occur in almost all organ systems of the human body. The worldwide incidence, approximately 0.5–5/100.000, is low, with almost 70 % occurring in the digestive system, another 20 % being diagnosed in the bronchopulmonary tract. Data from autopsy studies suggest that neuroendocrine tumors are an under-recognized malignancy [3]. Only 0.2 % of all neuroendocrine tumors (NETs) are located in the gallbladder. The most important prognostic factor is the level of proliferation, which determines the tumor grading. Overall, poorly differentiated NETs are aggressive tumors bearing a poor prognosis. …
Literature
1.
go back to reference Eltawil KM, Gustafsson BI, Kidd M, Modlin IM. Neuroendocrine tumors of the gallbladder: an evaluation and reassessment of management strategy. J Clin Gastroenterol. 2010;44:687–95.PubMed Eltawil KM, Gustafsson BI, Kidd M, Modlin IM. Neuroendocrine tumors of the gallbladder: an evaluation and reassessment of management strategy. J Clin Gastroenterol. 2010;44:687–95.PubMed
2.
go back to reference Iwasa S, Morizane C, Okusaka T, Ueno H, Ikeda M, Kondo S, et al. Cisplatin and etoposide as first-line chemotherapy for poorly differentiated neuroendocrine carcinoma of the hepatobiliary tract and pancreas. Jpn J Clin Oncol. 2010;40:313–8.CrossRefPubMed Iwasa S, Morizane C, Okusaka T, Ueno H, Ikeda M, Kondo S, et al. Cisplatin and etoposide as first-line chemotherapy for poorly differentiated neuroendocrine carcinoma of the hepatobiliary tract and pancreas. Jpn J Clin Oncol. 2010;40:313–8.CrossRefPubMed
3.
go back to reference Modlin IM, Moss SF, Oberg K, Padbury R, Hicks RJ, Gustafsson BI, et al. Gastrointestinal neuroendocrine (carcinoid) tumours: current diagnosis and management. Med J Aust. 2010;193:46–52.PubMed Modlin IM, Moss SF, Oberg K, Padbury R, Hicks RJ, Gustafsson BI, et al. Gastrointestinal neuroendocrine (carcinoid) tumours: current diagnosis and management. Med J Aust. 2010;193:46–52.PubMed
4.
go back to reference Rorstad O. Prognostic indicators for carcinoid neuroendocrine tumors of the gastrointestinal tract. J Surg Oncol. 2005;89:151–60.CrossRefPubMed Rorstad O. Prognostic indicators for carcinoid neuroendocrine tumors of the gastrointestinal tract. J Surg Oncol. 2005;89:151–60.CrossRefPubMed
5.
go back to reference Syversen U, Ramstad H, Gamme K, Qvigstad G, Falkmer S, Waldum HL. Clinical significance of elevated serum chromogranin A levels. Scand J Gastroenterol. 2004;39:969–73.CrossRefPubMed Syversen U, Ramstad H, Gamme K, Qvigstad G, Falkmer S, Waldum HL. Clinical significance of elevated serum chromogranin A levels. Scand J Gastroenterol. 2004;39:969–73.CrossRefPubMed
6.
go back to reference Zou YP, Li WM, Liu HR, Li N. Primary carcinoid tumor of the gallbladder: a case report and brief review of the literature. World J Surg Oncol. 2010;8:12.PubMedCentralCrossRefPubMed Zou YP, Li WM, Liu HR, Li N. Primary carcinoid tumor of the gallbladder: a case report and brief review of the literature. World J Surg Oncol. 2010;8:12.PubMedCentralCrossRefPubMed
Metadata
Title
Neuroendocrine Carcinoma of the Gallbladder Masquerading as a Klatskin Tumor in a 74-Year-Old Male
Authors
Fabian Kütting
Matthias Schmidt
Dirk Waldschmidt
Harald Curth
Christoph Schramm
Hans-Michael Steffen
Publication date
01-03-2016
Publisher
Springer US
Published in
Journal of Gastrointestinal Cancer / Issue 1/2016
Print ISSN: 1941-6628
Electronic ISSN: 1941-6636
DOI
https://doi.org/10.1007/s12029-015-9713-4

Other articles of this Issue 1/2016

Journal of Gastrointestinal Cancer 1/2016 Go to the issue